Journal
Nephrology dialysis transplantation
Publication Date
12-23-2025
Volume
41
Issue
1
First Page
161
Last Page
170
Document Type
Open Access Publication
DOI
10.1093/ndt/gfaf160
Rights and Permissions
Muthiah Vaduganathan, Jennifer B Green, Hiddo J L Heerspink, Sung Gyun Kim, Johannes F E Mann, Janet B McGill, Amy Mottl, Masaomi Nangaku, Julio Rosenstock, Peter Rossing, Li Li, Na Li, Katja Rohwedder, Charlie Scott, Rajiv Agarwal, Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial, Nephrology Dialysis Transplantation, Volume 41, Issue 1, January 2026, Pages 161–170, https://doi.org/10.1093/ndt/gfaf160. https://academic.oup.com/ndt/article/41/1/161/8244622?login=true. © The Author(s) 2025. Published by Oxford University Press on behalf of the ERA. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Vaduganathan, Muthiah; Green, Jennifer B; Heerspink, Hiddo J L; Kim, Sung Gyun; Mann, Johannes F E; McGill, Janet B; Mottl, Amy; Nangaku, Masaomi; Rosenstock, Julio; Rossing, Peter; Li, Li; Li, Na; Rohwedder, Katja; Scott, Charlie; and Agarwal, Rajiv, "Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial." Nephrology dialysis transplantation. 41, 1. 161 - 170. (2025).
https://digitalcommons.wustl.edu/oa_4/6003
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
